Exelixis
EXEL
#1680
Rank
C$14.21 B
Marketcap
$49.78
Share price
2.24%
Change (1 day)
67.67%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $68.85 CAD on 2000-07-26

Lowest end of day price: $1.80 CAD on 2014-12-24

Stock price history of Exelixis from 2000 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$47.48 0.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
$67.50 0.63%๐Ÿ‡ซ๐Ÿ‡ท France
$138.65-0.68%๐Ÿ‡บ๐Ÿ‡ธ USA
$82.30 1.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$411.75 1.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$216.93-0.21%๐Ÿ‡บ๐Ÿ‡ธ USA
$35.86 2.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.63-1.71%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.97 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA